How to ascertain drug safety in the context of benefit. Controversies and concerns.
Simon LS, Strand CV, Boers M, Brooks PM, Tugwell PS, Bombardier C, Fries JF, Henry D, Goldkind L, Guyatt G, Laupacis A, Lynd L, Macdonald T, Mamdani M, Moore A, Saag KG, Silman AJ, Stevens R, Tyndall A.
Simon LS, et al. Among authors: saag kg.
J Rheumatol. 2009 Sep;36(9):2114-21. doi: 10.3899/jrheum.090591.
J Rheumatol. 2009.
PMID: 19738223